About Irinotecam 40mg/2ml Injection
Irinotecam:-
Irinotecan is used alone or in combination with other medications to treat colon or rectal cancer (cancer that begins in the large intestine). Irinotecan is in a class of antineoplastic medications called topoisomerase I inhibitors. It works by stopping the growth of cancer cells.Irinotecan comes as a liquid to be given over 90 minutes intravenously (into a vein) by a doctor or nurse. It is usually given not more often than once a week, according to a schedule that alternates one or more weeks when you receive irinotecan with one or more weeks when you do not receive the medication. Your doctor will choose the schedule that will work best for you.
Effective Chemotherapy AgentIrinotecan 40mg/2ml Injection is widely utilized in oncology as a reliable chemotherapy agent. Its intravenous route guarantees direct delivery into the bloodstream, facilitating efficient absorption and action against cancer cells. This formulation has demonstrated efficacy as part of combination therapy regimens, often resulting in improved treatment outcomes.
Safety and Handling GuidelinesDue to its potent nature, Irinotecan Injection should only be handled by trained professionals. Contraindications include known hypersensitivity to irinotecan or any excipients in the product. Regular monitoring for neutropenia, diarrhea, and liver function is essential to ensure patient safety and efficacy of the treatment.
Storage and StabilityEnsure the injection is stored below 25C and away from light to maintain its stability. The product has a shelf life of 24 months from the date of manufacture, provided it is kept under the recommended conditions. Always check the product label for specific manufacturer details before administering.
FAQs of Irinotecam 40mg/2ml Injection:
Q: How is Irinotecan 40mg/2ml Injection administered?
A: This injection is administered intravenously by a qualified healthcare provider, usually in a hospital or clinical setting, to ensure patient safety and proper dosage.
Q: What are the main precautions to consider during Irinotecan treatment?
A: Patients must be monitored for neutropenia (low white blood cells), diarrhea, and liver impairment throughout treatment. Any signs of hypersensitivity should be reported immediately.
Q: When should Irinotecan Injection be avoided?
A: It should not be used in individuals with known hypersensitivity to irinotecan or its excipients. Always discuss your medical history with your doctor before starting treatment.
Q: Where should this injection be stored to preserve its effectiveness?
A: Store the vials below 25C and protect them from light. Follow manufacturer instructions for any additional storage recommendations and check expiration dates before use.
Q: What are the benefits of using Irinotecan in cancer therapy?
A: Irinotecan is effective in targeting and destroying cancer cells, often improving survival and quality of life when used as part of a comprehensive chemotherapy protocol.
Q: What is the process for preparing and administering this medication?
A: Preparation is typically done by qualified medical staff who may dilute the injection with compatible fluids like 5% Dextrose Injection before slow intravenous administration.
Q: Which ingredients are present in Irinotecan 40mg/2ml Injection?
A: The injection contains Irinotecan Hydrochloride, sterile water for injection, and other pharmaceutical-grade excipients, resulting in a clear, pale yellow, odorless solution.